“abide-therapeutics” Archives

in
Entry Author Date Location
Eying “Extra” DNA As Cancer Driver, Boundless Bio Debuts With $46M 09/19/19 San Diego
Lundbeck Paying Nearly $2B for Alder to Follow Migraine Rivals to Market 09/16/19 National
Science & Strategy Stars: Xconomy Awards San Diego Secret Weapon Finalists 05/15/19 Boston
Lundbeck to Buy Abide Therapeutics For $250M, Make SD Lab a US Hub 05/06/19 San Diego
Former Zavante Executive Tapped as Abide Therapeutics President 01/28/19 San Diego
West Coast Bio Roundup: Theranos, 23andMe, Invitae, Gritstone, Etc. 10/23/15 San Francisco
Celgene, Versant Shake Again, Cut $30M Deal For Toronto Biotech 04/29/15 New York
Try Then Buy? Sutro Deal Could Be Celgene’s Biggest Antibody Bet Yet 10/23/14 New York
San Diego Life Sciences Roundup: Thesan, Zogenix, Illumina, and More 02/28/14 San Diego
San Diego Life Sciences Roundup: Regulus, Ocera, Lithera, and More 07/18/13 San Diego
San Diego Life Sciences Roundup: Topera, Afraxis, Trovagene, & More 05/03/13 San Diego
Abide Therapeutics and Merck Unveil Diabetes Drug Collaboration 05/02/13 San Diego
Page 1 of 1